Anti-TNF levels not related to Crohn’s disease recurrence post op

Levels of anti-TNF drugs do not predict Crohn’s disease recurrence after surgery, an Australian trial shows. Adalimumab concentrations did not differ significantly between patients in endoscopic remission post intestinal resection and those who have a recurrence, the multicentre study found. The finding, from a sub-study of the Post-Operative Crohn’s Endoscopic Recurrence (POCER) study, suggests non-TNF-mediated ...

Already a member?

Login to keep reading.

© 2021 the limbic